-
Dr. Guillaume MOUILLET
Medical Doctor, Medical Oncology, IRFC-FC, University Hospital of Besançon - Epidemiologist at UMQVC
University Hospital of Besançongmouillet@chu-besancon.fr
Latest publications

ABSTRACTBackgroundSunitinib is a tyrosine kinase inhibitor approved in the first-line metastatic renal cell carcinoma...
Posted by : Dr. Guillaume MOUILLET, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Trials

BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...
Posted by : Dr. Sophie PAGET-BAILLY, Dr. Guillaume MOUILLET, Pr. Franck BONNETAIN
Journal name : PlosOne

AbstractNew combinations of antiangiogenic tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors (ICI) or...
Posted by : Dr. Guillaume MOUILLET
Journal name : Bulletin du cancer

ABSTRACTBACKGROUND: Two main therapies, pazopanib and sunitinib, are used in the first-line setting for metastatic renal...
Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, , Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH, Dr. Guillaume MOUILLET
Journal name : Health and Quality of Life Outcomes

Background: Deficient mismatch repair (dMMR) colon cancer (CC) is reportedly resistant to 5-fluorouracil (5FU) adjuvant...
Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Dr. Guillaume MOUILLET
Journal name : JNCI Journal of the National Cancer Institure

AbstractUntil recently, the first-line treatments used in metastatic renal cell carcinoma were based on first-generation...
Posted by : Dr. Guillaume MOUILLET
Journal name : Bulletin du cancer

AbstractIntroduction - Routine Electronic Monitoring of Health-Related Quality of Life (HRQoL) (REMOQOL) in clinical...
Posted by : Dr. Sophie PAGET-BAILLY, , , Mme. Joëlle FRITZSCH, Mr. Antoine FALCOZ, Dr. Guillaume MOUILLET
Journal name : Quality of Life Research

AbstractBackground Metastatic Squamous cell Penile Carcinoma (mSCPC) is an orphan disease with a virally induced...
Posted by : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY, Dr. Guillaume MOUILLET
Journal name : Bull Cancer

AbstractUntil recently, the first-line treatments used in metastatic renal cell carcinoma were based on first-generation...
Posted by : Dr. Guillaume MOUILLET
Journal name : Bulletin du cancer

AbstractBackground: Surgical resection with adjuvant chemotherapy is the only treatment that can provide long term...
Posted by : Dr. Dewi VERNEREY, Dr. Guillaume MOUILLET, Dr. Angélique VIENOT
Journal name : Front Oncol
Latest News
-
Tuesday, March 13 2018
The UMQVC has a Youtube channel! You can already watch video tutorials on the use of CHES. More content to come!
Latest tools
On Friday 17 November, the Quality of Life in Cancer conference, organized by the UMQVC with the support of the Pôle de...
Posted by : Dr. Sophie PAGET-BAILLY, Dr. Guillaume MOUILLET, Mme. Joëlle FRITZSCH